Raltegravir (Isentress)

Published November 13, 2007; Updated October 08, 2014
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-01
Selected Reference
1. Steigbigel RT, Cooper DA, Kumar PN, et al; BENCMRK Study Teams. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med. 2008 Jul 24;359(4):339-54.